Consolidated Balance Sheets (Parenthetical) - USD ($) |
Mar. 31, 2023 |
Dec. 31, 2022 |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Investment, cost | $ 3,797,714,000 | $ 3,773,752,000 | [1] | |||||||||||||||
Deferred financing costs, accumulated amortization | $ 11,003,000 | $ 10,603,000 | ||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||||||||||
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 | ||||||||||||||||
Common stock, shares outstanding (in shares) | 79,766,002 | 78,463,599 | ||||||||||||||||
Common stock, shares issued (in shares) | 79,766,002 | 78,463,599 | ||||||||||||||||
July 2026 Notes | Unsecured Notes | ||||||||||||||||||
Debt instrument, par value | $ 500,000,000 | $ 500,000,000 | ||||||||||||||||
May 2024 Notes | Unsecured Notes | ||||||||||||||||||
Debt instrument, par value | 450,000,000 | 450,000,000 | ||||||||||||||||
SBIC Debentures | Unsecured Notes | ||||||||||||||||||
Debt instrument, par value | 334,000,000 | 350,000,000 | ||||||||||||||||
Debt, due within one year | 63,800,000 | |||||||||||||||||
December 2025 Notes | Unsecured Notes | ||||||||||||||||||
Debt instrument, par value | 150,000,000 | 150,000,000 | ||||||||||||||||
Debt, due within one year | 100,000,000 | 100,000,000 | ||||||||||||||||
Control investments | ||||||||||||||||||
Investment, cost | 1,315,277,000 | [2],[3] | 1,270,802,000 | [1],[4] | ||||||||||||||
Affiliate investments | ||||||||||||||||||
Investment, cost | 591,458,000 | [3],[5] | 635,536,000 | [1],[6] | ||||||||||||||
Non‑Control/Non‑Affiliate investments | ||||||||||||||||||
Investment, cost | $ 1,890,979,000 | $ 1,867,414,000 | [1],[7] | |||||||||||||||
|